| Metric | FY 2001 | Prior Q | FY 2000 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $33M | — | — | — | — |
| Op. Income | $13M | — | — | — | — |
| Gross Margin | 54.1% | — | — | — | — |
| Net Margin | 25.4% | — | — | — | — |
| EPS (Diluted) | $0.06 | — | — | — | — |
| Free Cash Flow | $26M | — | $422M | — | -93.8% |
| Item | Amount |
|---|---|
| REVENUE | $33M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $18M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $20M |
| SG&A Expenses | $20M |
| Other Expenses | $15M |
| Operating Expenses | $35M |
| Cost & Expenses | $50M |
| OPERATING INCOME | $13M |
| Interest Income | $216M |
| Interest Expense | $15M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $8M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $1M |
| EBIT | $0 |
| EBITDA | $29M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $33M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $18M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $20M |
| SG&A Expenses | $20M |
| Other Expenses | $15M |
| Operating Expenses | $35M |
| Cost & Expenses | $50M |
| OPERATING INCOME | $13M |
| Interest Income | $216M |
| Interest Expense | $15M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $8M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $1M |
| EBIT | $0 |
| EBITDA | $29M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $8M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | -$1.7B |
| Change in Working Capital | $1.7B |
| OPERATING CASH FLOW | $27M |
| Capital Expenditure | -$1M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$78M |
| Sales/Maturities of Investments | $29M |
| Other Investing Activities | $11M |
| NET CASH FROM INVESTING | -$40M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $89M |
| Common Dividends Paid | -$85M |
| Other Financing Activities | $394M |
| NET CASH FROM FINANCING | $309M |
| FREE CASH FLOW | $26M |
| Net Change in Cash | -$513M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $184.0K |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $21.5B |
| TOTAL CURRENT ASSETS | $21.5B |
| PP&E (Net) | $273M |
| Goodwill | $173M |
| Intangible Assets | $0 |
| Long-Term Investments | -$453M |
| Tax Assets | $453M |
| Other Non-Current Assets | -$210M |
| TOTAL NON-CURRENT ASSETS | $173M |
| TOTAL ASSETS | $21.6B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $453M |
| Other Current Liabilities | $17.0B |
| TOTAL CURRENT LIABILITIES | $17.4B |
| Long-Term Debt | $2.2B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $2.2B |
| TOTAL LIABILITIES | $19.6B |
| Common Stock | $1M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $8M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $16M |
| Other Equity | $2.0B |
| TOTAL STOCKHOLDERS' EQUITY | $2.0B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.0B |
| TOTAL LIABILITIES & EQUITY | $21.6B |
| Total Debt | $1.6B |
| Net Debt | $3.2B |
